ZWJ Investment Counsel Inc. Boosts Stake in Innospec Inc. (NASDAQ:IOSP)

ZWJ Investment Counsel Inc. lifted its holdings in Innospec Inc. (NASDAQ:IOSP) by 5.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,936 shares of the specialty chemicals company’s stock after purchasing an additional 2,115 shares during the quarter. ZWJ Investment Counsel Inc. owned 0.17% of Innospec worth $5,168,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of IOSP. Belpointe Asset Management LLC increased its position in Innospec by 226.2% during the first quarter. Belpointe Asset Management LLC now owns 274 shares of the specialty chemicals company’s stock valued at $28,000 after acquiring an additional 190 shares during the last quarter. Captrust Financial Advisors grew its holdings in Innospec by 74.7% during the first quarter. Captrust Financial Advisors now owns 498 shares of the specialty chemicals company’s stock valued at $46,000 after purchasing an additional 213 shares during the period. Point72 Hong Kong Ltd bought a new stake in Innospec during the first quarter valued at about $53,000. Point72 Middle East FZE bought a new stake in Innospec during the fourth quarter valued at about $57,000. Finally, UBS Group AG grew its holdings in Innospec by 71.6% during the third quarter. UBS Group AG now owns 1,009 shares of the specialty chemicals company’s stock valued at $86,000 after purchasing an additional 421 shares during the period. Hedge funds and other institutional investors own 96.64% of the company’s stock.

Insider Transactions at Innospec

In other news, VP Philip John Boon sold 3,715 shares of the company’s stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $122.07, for a total value of $453,490.05. Following the completion of the transaction, the vice president now owns 18,516 shares of the company’s stock, valued at $2,260,248.12. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CEO Patrick Williams sold 9,667 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $124.37, for a total value of $1,202,284.79. Following the completion of the transaction, the chief executive officer now owns 174,334 shares of the company’s stock, valued at $21,681,919.58. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Philip John Boon sold 3,715 shares of the stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $122.07, for a total value of $453,490.05. Following the transaction, the vice president now directly owns 18,516 shares of the company’s stock, valued at $2,260,248.12. The disclosure for this sale can be found here. Insiders sold a total of 36,500 shares of company stock valued at $4,532,959 over the last 90 days. Company insiders own 1.52% of the company’s stock.

Innospec Stock Up 1.2 %

NASDAQ:IOSP traded up $1.46 during mid-day trading on Friday, hitting $122.28. 67,128 shares of the company traded hands, compared to its average volume of 89,120. The stock’s fifty day moving average price is $124.29 and its 200-day moving average price is $115.19. Innospec Inc. has a one year low of $91.74 and a one year high of $131.18. The firm has a market cap of $3.05 billion, a price-to-earnings ratio of 21.95 and a beta of 1.10.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.59 by $0.25. The business had revenue of $494.70 million during the quarter, compared to analyst estimates of $479.47 million. Innospec had a return on equity of 13.69% and a net margin of 7.14%. Innospec’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.20 earnings per share. Equities analysts predict that Innospec Inc. will post 6.77 EPS for the current year.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.